lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p

Table 1

The association between clinical features and the MEG3 level in individuals with malignant melanoma.

Clinicopathological finding	Patients	MEG3		value
		High	Low
Age (years)
≦60	25	13	12	0.753
>60	17	8	9
Sex
Male	21	12	9	0.355
Female	21	9	12
Tumor thickness (mm)
≤1	16	12	4	0.011
>1	26	9	17
TNM classification
I + II	17	13	4	0.005
III + IV	25	8	17
Lymph node involvement
No	19	16	3	0.000
Yes	23	5	18
Distant metastasis
No	27	19	8	0.000
Yes	15	2	13